{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03143153", "pid": "29", "mcid": "2106", "text": "any positive test result for hepatitis b or c indicating acute or chronic infection and/or detectable virus", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03125902", "pid": "29", "mcid": "2817", "text": "negative hepatitis c virus (hcv) antibody test at screening or positive hcv antibody test followed by a negative hcv rna test at screening. the hcv rna test will be performed only for patients who have a positive hcv antibody test.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03056339", "pid": "29", "mcid": "6431", "text": "known positive serology for hiv.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02911792", "pid": "29", "mcid": "12575", "text": "positive serologic evidence of current infectious liver disease including hepatitis b viral antibody igm, hepatitis b surface antigen, hepatitis c virus antibody and hiv", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02833805", "pid": "29", "mcid": "14796", "text": "active hepatitis b or c infection determined by serology and/or nucleic acid testing (nat)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02822378", "pid": "29", "mcid": "15191", "text": "positive for hiv, hep-c or hep-b surface antigen and malignancy.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02772562", "pid": "29", "mcid": "16438", "text": "positive hepatitis c serology or active hepatitis b infection.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02670044", "pid": "29", "mcid": "19137", "text": "positive for hepatitis c virus (hcv), hepatitis b surface antigen (hbsag) and known history of hiv, malignancy, active infection and cardiovascular diseases (cvs)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02628535", "pid": "29", "mcid": "20225", "text": "known history of hepatitis b or c infection or known positive test for hepatitis b surface antigen or core antigen or hepatitis c polymerase chain reaction (pcr)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02570854", "pid": "29", "mcid": "22559", "text": "a positive hepatitis b surface antigen test result. patients with hepatitis c virus (hcv) infection may be included if all other liver function eligibility criteria are met.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02552953", "pid": "29", "mcid": "23646", "text": "known active hepatitis b and/or hepatitis c infection", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02512497", "pid": "29", "mcid": "25896", "text": "evidence of either cirrhosis or stage 3-4 liver fibrosis in patients with chronic hepatitis c or positive hepatitis c serology.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02471430", "pid": "29", "mcid": "28220", "text": "negative hepatitis b surface antigen (hbsag) or negative hbv dna pcr", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01562626", "pid": "29", "mcid": "50480", "text": "patients with evidence of chronic active hepatitis b (positive for hbsag) and hepatitis c (positive for viral rna).", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02446236", "pid": "29", "mcid": "29590", "text": "known human immunodeficiency virus (hiv-1) infection or chronic hepatitis b or c (hep b serology positive without active infection will be eligible)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02411656", "pid": "29", "mcid": "31087", "text": "has a known active hepatitis b or hepatitis c", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02374333", "pid": "29", "mcid": "32631", "text": "active hepatitis b or hepatitis c infection.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01599559", "pid": "29", "mcid": "50080", "text": "known hiv-positive serology.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02342782", "pid": "29", "mcid": "34012", "text": "active hepatitis b or c viral infection or hepatitis b surface antigen positive", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02311361", "pid": "29", "mcid": "35548", "text": "true positive test results for hepatitis a (immunoglobulin m (igm) positive). subjects with a history of hepatitis a with immunoglobulin g (igg) blood test are not excluded. true positive test results hepatitis b or c infection.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02236000", "pid": "29", "mcid": "37755", "text": "active hepatitis b or hepatitis c with abnormal liver function tests; hiv positive patients receiving antivirals.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02215096", "pid": "29", "mcid": "38242", "text": "presence of hepatitis b surface antigen (hbsag), positive hepatitis c antibody test result at screening or within 3 months prior to first dose of study treatment.", "entities": [{"id": 551, "label": "TVariable", "start_offset": 49, "end_offset": 103}, {"id": 552, "label": "TCreLt", "start_offset": 107, "end_offset": 113}, {"id": 553, "label": "TValue", "start_offset": 114, "end_offset": 115}, {"id": 554, "label": "TUnit", "start_offset": 116, "end_offset": 122}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02200445", "pid": "29", "mcid": "38754", "text": "positive serology for hiv, hepatitis b virus (hbv) or hcv.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02158793", "pid": "29", "mcid": "40123", "text": "positive serology for hiv; hepatitis b/c antigen", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02075710", "pid": "29", "mcid": "42629", "text": "positive hiv antibody test or hepatitis serologies", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01883076", "pid": "29", "mcid": "46674", "text": "mother's serology test results are negative for hiv, hepatitis b and hepatitis c.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01823198", "pid": "29", "mcid": "47436", "text": "hepatitis b surface antigen negative and hepatitis c antibody negative", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01734512", "pid": "29", "mcid": "48546", "text": "hepatitis b/c blood test must be done at screening for all patients. patients who test positive for hepatitis c antibodies and the hepatitis b antigen are ineligible.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01140087", "pid": "29", "mcid": "52557", "text": "positive for hepatitis b or c", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00720785", "pid": "29", "mcid": "53655", "text": "active hepatitis b infection (hep b surface antigen positive)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00713492", "pid": "29", "mcid": "53768", "text": "positive hepatitis a, b antigen or c or hiv test at screening.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00357565", "pid": "29", "mcid": "54250", "text": "history of hiv infection or known positive serology", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02776761", "pid": "29", "mcid": "16333", "text": "negative hantavirus psvna test result at screening", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01703117", "pid": "29", "mcid": "48872", "text": "positive hepatitis serology (hep. b antigen+ or hep. c antibody+)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03113695", "pid": "29", "mcid": "3461", "text": "positive hepatitis serology", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02946658", "pid": "29", "mcid": "11154", "text": "patients positive for hepatitis (hepatitis a history excepted)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02315196", "pid": "29", "mcid": "35334", "text": "known or active hepatitis b or c with abnormal liver function tests", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01940757", "pid": "29", "mcid": "45723", "text": "positive confirmatory test for hiv infection.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01773395", "pid": "29", "mcid": "48192", "text": "positive hiv or htlv-1 serology", "entities": [], "relations": [], "Comments": []}
